These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25144827)

  • 1. Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis.
    Collard HR; Brown KK; Martinez FJ; Raghu G; Roberts RS; Anstrom KJ
    Chest; 2014 Nov; 146(5):1256-1262. PubMed ID: 25144827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials.
    King TE; Albera C; Bradford WZ; Costabel U; du Bois RM; Leff JA; Nathan SD; Sahn SA; Valeyre D; Noble PW
    Am J Respir Crit Care Med; 2014 Apr; 189(7):825-31. PubMed ID: 24476390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes after hospitalization in idiopathic pulmonary fibrosis: a cohort study.
    Brown AW; Fischer CP; Shlobin OA; Buhr RG; Ahmad S; Weir NA; Nathan SD
    Chest; 2015 Jan; 147(1):173-179. PubMed ID: 25188694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.
    Ley B; Swigris J; Day BM; Stauffer JL; Raimundo K; Chou W; Collard HR
    Am J Respir Crit Care Med; 2017 Sep; 196(6):756-761. PubMed ID: 28471697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalizations in patients with idiopathic pulmonary fibrosis.
    Kim HJ; Snyder LD; Adegunsoye A; Neely ML; Bender S; White ES; Conoscenti CS; Strek ME;
    Respir Res; 2021 Sep; 22(1):257. PubMed ID: 34592998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs.
    Alqalyoobi S; Fernández Pérez ER; Oldham JM
    BMC Pulm Med; 2020 Nov; 20(1):289. PubMed ID: 33160338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
    Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
    Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
    Peljto AL; Zhang Y; Fingerlin TE; Ma SF; Garcia JG; Richards TJ; Silveira LJ; Lindell KO; Steele MP; Loyd JE; Gibson KF; Seibold MA; Brown KK; Talbert JL; Markin C; Kossen K; Seiwert SD; Murphy E; Noth I; Schwarz MI; Kaminski N; Schwartz DA
    JAMA; 2013 Jun; 309(21):2232-9. PubMed ID: 23695349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.
    Newton CA; Zhang D; Oldham JM; Kozlitina J; Ma SF; Martinez FJ; Raghu G; Noth I; Garcia CK
    Am J Respir Crit Care Med; 2019 Aug; 200(3):336-347. PubMed ID: 30566847
    [No Abstract]   [Full Text] [Related]  

  • 10. Composite end points of death and hospitalization are the only appropriate option for most trials.
    Latar I; Girerd N
    Chest; 2015 May; 147(5):e189. PubMed ID: 25940263
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of Idiopathic Pulmonary Fibrosis on Longitudinal Health-care Utilization in a Community-Based Cohort of Patients.
    Farrand E; Iribarren C; Vittinghoff E; Levine-Hall T; Ley B; Minowada G; Collard HR
    Chest; 2021 Jan; 159(1):219-227. PubMed ID: 32717266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
    Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
    Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial.
    Wilson AM; Clark AB; Cahn T; Chilvers ER; Fraser W; Hammond M; Livermore DM; Maher TM; Parfrey H; Swart AM; Stirling S; Thickett DR; Whyte M;
    JAMA; 2020 Dec; 324(22):2282-2291. PubMed ID: 33289822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.
    de Andrade JA; Kulkarni T; Neely ML; Hellkamp AS; Case AH; Culver DA; Guntupalli K; Bender S; Conoscenti CS; Snyder LD;
    Respir Res; 2022 Jan; 23(1):3. PubMed ID: 34996465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-of-life care of patients with idiopathic pulmonary fibrosis.
    Rajala K; Lehto JT; Saarinen M; Sutinen E; Saarto T; Myllärniemi M
    BMC Palliat Care; 2016 Oct; 15(1):85. PubMed ID: 27729035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis: A Population-Based Cohort Study.
    Tran T; Assayag D; Ernst P; Suissa S
    Chest; 2021 Feb; 159(2):673-682. PubMed ID: 32882251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
    Aggarwal R; McBurney C; Schneider F; Yousem SA; Gibson KF; Lindell K; Fuhrman CR; Oddis CV
    Rheumatology (Oxford); 2017 Mar; 56(3):384-389. PubMed ID: 28082622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bundled care approach to patients with idiopathic pulmonary fibrosis improves transplant-free survival.
    Kulkarni T; Willoughby J; Acosta Lara Mdel P; Kim YI; Ramachandran R; Alexander CB; Luckhardt T; Thannickal VJ; de Andrade JA
    Respir Med; 2016 Jun; 115():33-8. PubMed ID: 27215501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Kramer MR
    Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.